Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
about
New and contemporary markers of prognosis in nonmuscle invasive urothelial cancerCell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomenaCost of care for cancer patients in England: evidence from population-based patient-level data.Treatment and Survival of Medicare Beneficiaries with Colorectal Cancer: A Comparative Analysis Between a Rural State Cancer Registry and National Data.Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?Provider perceptions of colorectal cancer screening clinical decision support at three benchmark institutionsIdentification of a bladder cancer-specific ligand using a combinatorial chemistry approachFGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.Cost-effectiveness of early detection of breast cancer in Catalonia (Spain).Identifying potential need for cancer palliation in Nova Scotia.Lifetime economic burden of prostate cancer.Evolution of breast cancer screening in the Medicare population: clinical and economic implications.Cost of care for cancer in a health maintenance organization.Are breast cancer navigation programs cost-effective? Evidence from the Chicago Cancer Navigation ProjectA comparative analysis of monthly out-of-pocket costs for patients with breast cancer as compared with other common cancers in Ontario, Canada.The need for online information on the economic consequences of cancer diagnosis, treatment, and survivorship.End-of-life care for lung cancer patients in the United States and Ontario.Differences among the elderly in the treatment costs of colorectal cancer: how important is race?Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003Economic burden of cancer in the United States: estimates, projections, and future researchEconomic impact of disease progression in follicular non-Hodgkin lymphoma.End-of-Life Medical Costs of Medicaid Cancer Patients.Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada.Evaluation of trends in the cost of initial cancer treatmentLong-term costs of colorectal cancer treatment in SpainA new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivoUnderstanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE).A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissionsCosts of medical care after open or minimally invasive prostate cancer surgery: a population-based analysisEconomic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative.Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.The cost of breast cancer screening in the Medicare population.Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.Regional variation in spending and survival for older adults with advanced cancerManagement of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?Provider treatment intensity and outcomes for patients with early-stage bladder cancer.Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer.Costs and trends in pancreatic cancer treatmentOverview of methods to estimate the medical costs of cancerCost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening.
P2860
Q26798006-414D6B63-2406-46CE-BF55-BB41C86D214BQ26860953-69A1122B-A869-4DA8-B9BE-36D85CA6C280Q31075231-3063BFAB-AF89-4FBE-B344-FC5A4E1823A7Q31114899-C2868A6B-0BB9-491A-855A-50DC273E4F49Q33470183-FD463C1C-9022-48B2-ADE4-61858E4C7659Q33626616-85C9A773-16F1-4681-91EB-54E0C3FF0304Q33708339-B15E76F4-724A-424E-96D3-20E262B8C9A6Q33745140-37236FFE-EA82-417A-B5D0-E33149EB8214Q33909250-0AF7BE3C-21C0-4475-850B-E2E52080B524Q34028950-723FC281-6ED4-46F0-BF4A-99F0EF9DFD63Q34113013-DC9F015E-1473-43CB-9B8D-10CC6CA87F6DQ34137696-CBF22286-C411-4A22-89A1-232A91C65581Q34326216-25556378-C69E-4782-B830-8126ACDB643DQ34424738-FDD48A45-45E6-43E1-89F8-295139D9289EQ34541453-195AF26F-8D42-4373-99E5-1C6F05BFDF4AQ34998548-56EFB516-C5DE-48BF-86D8-E0E432B7FE15Q35047094-D4A213B0-A866-4B97-8130-D4AA3B839209Q35071410-1F293E74-8786-406F-8BC8-6A2F3AB22D1CQ35148957-4A9C6862-73F6-4503-A3BE-9F6DA15F51B2Q35327245-1FC5D93D-E446-4D28-B7AC-4F7E0B4D0AC3Q35536558-F7DC6A09-76BA-4AAA-8755-C0BC3F61F9EAQ35670713-01212997-067A-465A-AA71-5AA262A379B6Q35736201-6BDF1BA5-8A59-4A6C-9B6E-E704CC20CA7AQ35820277-0B40A944-B034-43E8-9A4B-30856FC92556Q35925257-66D31862-4F9E-4008-98E0-2FA3D0CFDCB6Q36028618-468BF607-7DED-44DC-8F84-E918531E0644Q36195211-AC7DAF35-FE84-4AA9-8226-4527307A999CQ36296607-B948A008-18E5-42C4-8E73-A5EEFD16432FQ36344962-E843C703-088F-4D6C-81B4-6C972088BBA6Q36409170-BAA0C99F-3385-47CA-B7FC-DEE3F9E6AC68Q36619134-1E8CD1C9-6BA2-46C0-8BD1-6CE8F1D244CDQ36802201-A1E2D7D6-7BD1-48EC-8CDB-53F3491541DCQ36945929-529305E4-5E34-4957-BD94-2D8C6313E759Q36953580-75CCC599-D52F-4F5D-8B1A-C6B2A98B756CQ37053829-E5F7CFD1-8EC3-4DF4-9492-20705AF46981Q37158594-3A6748E7-C891-4FE7-96E1-6F7043B46263Q37197530-785030E6-9F2B-4401-B4D1-ED58E22624CFQ37246292-FFE93589-4F97-49D3-ACF7-6D9CE1104448Q37286387-E05C1613-9C8C-4FAC-A290-F8C877F4BC6AQ37345335-85A55584-17E5-40AD-8299-185550FB372E
P2860
Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Medicare payments from diagnos ...... atients by stage at diagnosis.
@en
Medicare payments from diagnos ...... atients by stage at diagnosis.
@nl
type
label
Medicare payments from diagnos ...... atients by stage at diagnosis.
@en
Medicare payments from diagnos ...... atients by stage at diagnosis.
@nl
prefLabel
Medicare payments from diagnos ...... atients by stage at diagnosis.
@en
Medicare payments from diagnos ...... atients by stage at diagnosis.
@nl
P2093
P1433
P1476
Medicare payments from diagnos ...... patients by stage at diagnosis
@en
P2093
A L Potosky
J D Lubitz
L G Kessler
P304
P356
10.1097/00005650-199508000-00007
P577
1995-08-01T00:00:00Z